Gene silencing in thalassemia

Minerva Biotecnologica

Volumn 20, Issue 1, 2008, Pages 51-55

  Bianchi, N ^a   Borgatti, M ^a   Gambari, R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Beta thalassemia; Fetal hemoglobin; Gene silencing; Globins; Oligonucleotides

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; HEMOGLOBIN F; HYDROXYUREA; MESSENGER RNA; SHORT HAIRPIN RNA;

ANEMIA; ANTISENSE THERAPY; BETA THALASSEMIA; BLOOD TRANSFUSION; CONFERENCE PAPER; DOWN REGULATION; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; GENE REPRESSION; GENE SILENCING; GENE THERAPY; HEMOGLOBIN SYNTHESIS; HEMOLYSIS; HUMAN; NONHUMAN; PHENOTYPE; POSTTRANSCRIPTIONAL GENE SILENCING; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

EID: 48349088011     PISSN: 11204826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cao A and Moi P. Genetic modifying factors in beta-thalassemia. Clin Chem Lab Med 2000;38:123-32.
2. Ho PJ. The regulation of beta globin gene expression and beta thalassemia. Pathology 1999;31:315-24.
3. Wealtherall DJ, Clegg JB. The thalassemia syndromes. Oxford Blackwell Scientific 2001;133-91.
4. Eleftheriou A. The pathophysiology of thalassaemia: Lack of b-chains and excess of a-chains. In: About Thalassemia. The Thalassemia International Federation publisher 2007; pp. 16-8.
5. Schrier SL. Pathophysiology of thalassemia. Curr Opin Hematol 2002;9:123-6.
6. Traeger-Synodinos J, Papassotiriou I, Vrettou C, Skarmoutsou C, Stamoulakatou A, Kanavakis E. Erythroid marrow activity functional anemia in patients with the rare interaction of a single functional α-globin and β-globin gene. Haematologica 2001;86:363-7.
7. Lai MI, Jiang J, Silver N, Best S, Menzel S, Mijovic A et al. Alpha-haemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of beta-thalassaemia. Br J Haematol 2006;133:675-82.
8. Gambari R, Fibach E. Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia. Curr Med Chem 2007;14:199-212.
9. Gu X, Zeng Y. A review of the molecular diagnosis of thalassemia. Hematology 2002;7:203-9.
10. Bank A. Regulation of human fetal hemoglobin: new players, new complexities. Blood 2006;107:435-43.
11. Voon HP, Wardan H, Vadolas J. Co-inheritance of a- and b-thalassaemia in mice ameliorates thalassaemic phenotype. Blood Cells Mol Dis 2007;39:184-8.
12. Piras I, Vona G, Falchi A, Latini V, Ristaldi S, Vacca L et al. Beta-globin cluster haplotypes in normal individuals and b(0)39-thalassemia carriers from Sardinia, Italy. Am J Hum Biol 2005;17:765-72.
13. Colosimo A, Guida V, Scolari A, De Luca A, Palka G, Rigoli L et al. Validation of dHPLC for molecular diagnosis of b-thalassemia in Southern Italy. Genet Test 2003;7:269-75.
14. Feriotto G, Salvatori F, Finotti A, Breveglieri G, Venturi M, Zuccato C et al. A novel frame shift mutation (+A) at codon 18 of the b-globin gene associated with HPFH phenotype and b°-thalassemia. Acta Haematologica 2008;119:28-37.
15. Mo QH, Li XR, Li CF, He YL, Xu XM. A novel frameshift mutation (+G) at codons 15/16 in a b0-thalassaemia gene results in a significant reduction of beta globin mRNA values. J Clin Pathol 2005;58:923-6.
16. Forget BG. Molecular basis of hereditary persistence of fetal hemoglobin. Ann N Y Acad Sci 1998;850:38-44.
17. Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev 2003;17:43-53.
18. Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S et al. Hydroxyurea in thalassemia intermedia - a promising therapy. Ann Hematol 2005;84:441-6.
19. Bank A. Understanding globin regulation in b-thalassemia: it's as simple as a, b, g, d. J Clin Invest 2005;6:1470-3.
20. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA. RNA interference in adult mice. Nature 2002;418:38-9.
21. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002;16:948-58.
22. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003;33:401-6.
23. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-11.
24. Borgatti M, Finotti A, Romanelli A, Saviano M, Bianchi N, Lampronti I et al. Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression. Curr Drug Targets 2004;5:735-44.
25. Piva R, Penolazzi L, Zennaro M, Bianchini E, Magri E, Borgatti M et al. Induction of apoptosis of osteoclasts by targeting transcription factors with decoy molecules. Ann N Y Acad Sci 2006;1091:509-16.
26. Lambertini E, Penolazzi L, Tavanti E, Pocaterra B, Schincaglia GP, Torreggiani E et al. Modulation of expression of specific transcription factors involved in the bone microenvironment. Minerva Biotec 2008;20:69-78.
27. Xie SY, Ren ZR, Zhang JZ, Guo XB, Wang QX, Wang S et al. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach. Hum Mol Genet 2007;16:2616-25.
28. Bianchi N, Feriotto G, Gambari R, Mischiati C. Synthetic oligonucleotides as inducers of erythroid differentiation. United States Patent US 7,262,175 B2, August 28, 2007.